Related Targets |
Mechanism GR agonists [+3] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. IN |
First Approval Date01 May 2020 |
Mechanism GR agonists [+3] |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Mechanism GR agonists [+3] |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date28 Feb 2026 |
Sponsor / Collaborator |
Start Date22 Mar 2018 |
Sponsor / Collaborator |
Start Date27 Jan 2016 |
Sponsor / Collaborator GSK Plc [+1] |